Moderna MRNA Total costs & expenses

Total costs & expenses at other companies

NovavaxNVAX

$111.6M-19.2%

ALN

Alnylam PharmaceuticalsALNY

$1.06B+34.1%

Gilead SciencesGILD

$18.2B+295%

FAQ

What is Moderna's total costs & expenses?

Moderna (MRNA) reported total costs & expenses of $1.78B in Q1 2026.

How has Moderna's total costs & expenses changed year-over-year?

Moderna's total costs & expenses increased by 53.5% year-over-year, from $1.16B to $1.78B.

What is the long-term trend for Moderna's total costs & expenses?

Over 4 years (2021 to 2025), Moderna's total costs & expenses has grown at a -0.8% compound annual growth rate (CAGR), from $5.18B to $5.02B.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating and non-operating costs incurred by a company to support its business activities during a specific period. It encompasses the cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure allows investors to evaluate the company's overall cost structure and the efficiency of its resource allocation relative to revenue generation.